Latest Breaking News On - Indevus pharmaceuticals - Page 1 : comparemela.com

AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders

Highlights AIM’s Significant Momentum and Ongoing Achievement of Clinical and Regulatory Milestones Urges Shareholders to Protect AIM’s Progress by Voting for the Company’s Board of Directors.

United statesThomask equelsMichaelj xirinachsFranzn tudorAstrazeneca imfinziWilliamm mitchellRobertl chioiniNancyk bryanStewartl appelrouthTedd kellnerEarly access programAmerican journal of cancer researchCompany on twitterGroup is notIndevus pharmaceuticalsUniversity of nebraska

AIM ImmunoTech Bolsters Board of Directors with Appointment

OCALA, Fla., March 30, 2023 (GLOBE NEWSWIRE) AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on.

United statesPhi beta kappaWilliam mitchellNancyk bryanBayer pharmaceuticalsColumbia universityVanderbilt university school of medicineUniversity of virginiaBioflorida incIndevus pharmaceuticalsImmunotech incCompany on twitterVanderbilt university schoolBeta gammaPrivate securities litigation reform actNyse aim

AIM ImmunoTech Bolsters Board of Directors with Appointment of Pharmaceutical Industry Veteran Nancy K Bryan, with Deep Commercial, Marketing, Business Development and Corporate Finance Expertise

AIM ImmunoTech Bolsters Board of Directors with Appointment of Pharmaceutical Industry Veteran Nancy K Bryan, with Deep Commercial, Marketing, Business Development and Corporate Finance Expertise
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPhi beta kappaWilliam mitchellNancyk bryanImmunotech incIndevus pharmaceuticalsUniversity of virginiaCompany on twitterVanderbilt university school of medicineBioflorida incColumbia universityBayer pharmaceuticalsVanderbilt university schoolBeta gammaPrivate securities litigation reform act

PaxMedica Appoints Specialty Pharma Industry Leader Charles

Founder of several public life sciences companies including Questcor, Osteologix and Indevus, Casamento will serve as an Independent Director TARRYTOWN,.

New yorkUnited statesNew jerseyIona collegeFordham universityCharles chuckj casamentoHoward weismanIndevus pharmaceuticals incQuestcor pharmaceuticals incFordham university college of pharmacySandoz international gmbhAudit committeePaxmedica incRelmada therapeutics incFirst wave biopharma incProduct development

Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors

31.01.2022 - MORRISVILLE, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) - Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases . Seite 1

New yorkUnited statesUnion collegeIndevus pharmaceuticals incStackpole corporationUnion college in schenectadyFortress biotech incSchochet associates incChief financial officerFortress biotechFrom augustCorporate controllerSenior vice presidentSchochet associatesIndevus pharmaceuticalsAccounting manager